p63 Protein + HMW Cytokeratin (Basal Cell Marker) antibody

Details for Product No. ABIN93860, Supplier: Log in to see
Clonality (Clone)
Monoclonal ()
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
Log in to see
Supplier Product No.
Log in to see

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Immunogen Recombinant human p63 protein (aa 1-205) and cytokeratin extract of human stratum corneum
Clone 4A4-34betaE12
Isotype IgG1, IgG2a
Specificity Nuclear p63 and cytoplasmic high molecular weight cytokeratins
Research Area Cancer, Signaling, Apoptosis/Necrosis
Application Notes IHC(P) , neat , Positive Control: Normal prostate tissue or skin
Restrictions For Research Use only
Format Liquid
Concentration 0,5+0,5
Buffer stabilizing phosphate buffer pH 7.3. Contains 0.09 % sodium azide. The volume is sufficient for at least 100 immunohistochemical tests (100 ul working solution / test)
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C
Background publications Browne TJ,Hirsch MS,Brodsky G,Welch WR,Loda MF,Rubin MA: "Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens." in: Hum Pathol, Vol. 35, Issue 12, pp. 1462-8, 2004 (PubMed).

Weinstein MH,Signoretti S,Loda M: "Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells." in: Mod Pathol, Vol. 15, Issue 12, pp. 1302-8, 2002 (PubMed).

Signoretti, Waltregny, Dilks, Isaac, Lin, Garraway, Yang, Montironi, McKeon, Loda: "p63 is a prostate basal cell marker and is required for prostate development." in: The American journal of pathology, Vol. 157, Issue 6, pp. 1769-75, 2000 (PubMed).

Yang, Lecksell, Gaudin, Epstein: "Rare expression of high-molecular-weight cytokeratin in adenocarcinoma of the prostate gland: a study of 100 cases of metastatic and locally advanced prostate cancer." in: The American journal of surgical pathology, Vol. 23, Issue 2, pp. 147-52, 1999 (PubMed).